Top Markets
Coin of the day
MetaStat Inc MetaStat Inc

MetaStat Inc

MTST
Rang in Aktien #42020
MetaStat, Inc., a precision medicine company, focuses on discovering and... MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company’s therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.
Aktienkurs
$0.001
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$5.88K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
400.00%
Land
US
Handel MetaStat Inc (MTST)

Kategorie

Kursverlauf für MetaStat Inc (MTST)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $8.64K am 2009-01-01
Kursverlauf der Aktie von MetaStat Inc von 2009 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 463.64%
2024 0.00%
2023 0.00%
2022 -94.49%
2021 -97.16%
2020 -66.02%
2019 -80.17%
2018 -86.53%
2017 -59.23%
2016 -66.02%
2015 -30.12%
2014 -67.24%
2013 -59.82%
2012 145.63%
2011 -91.79%
2010 111.42%
2009 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$57.00 49.47%
CN
$108.57 62.31%
CH
$460.07 28.69%
IE
$287.89 109.53%
US
$8.66 81.64%
TH